CYTOGENETICS AND MOLECULAR GENETICS IN MULTIPLE MYELOMA - 09/09/11

Doi : 10.1016/S0889-8588(05)70412-3

Rena Feinman, MD, PhD ^{^{*
From the Division of Hematology/Oncology and Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas}}, Jeffrey Sawyer, PhD ^{^{*
From the Division of Hematology/Oncology and Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas}}, James Hardin, PhD ^{^{*
From the Division of Hematology/Oncology and Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas}}, Guido Tricot, MD, PhD ^{^{*
From the Division of Hematology/Oncology and Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas}}

Mappa

CYTOGENETICS IN MULTIPLE MYELOMA

Type of Cytogenetic Abnormalities

Prognostic Significance of Cytogenetics in Multiple Myeloma

MOLECULAR GENETICS

The Role of Tumor Suppressor Gene Products in Multiple Myeloma

Hypothetical Model of Myeloma Development

CONCLUSION

Address reprint requests to Rena Feinman, PhD Arkansas Cancer Research Center 4301 W. Markham, Slot 508 Little Rock, AR 72205
This work was supported in part by Grant CA55819 from the National Cancer Institute, Bethesda, Maryland, and Ares-Serono, Geneva, Switzerland.

Esportazione

Vol 11 - N° 1

P. 1-25 - febbraio 1997 Ritorno al numero

Articolo precedente

PREFACE
B.A.R.T. BARLOGIE

| Articolo seguente

INTERACTION OF TUMOR AND HOST CELLS WITH ADHESION AND EXTRACELLULAR MATRIX MOLECULES IN THE DEVELOPMENT OF MULTIPLE MYELOMA
Gerrard Teoh, Kenneth C. Anderson

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

CYTOGENETICS AND MOLECULAR GENETICS IN MULTIPLE MYELOMA - 09/09/11

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL